Navigation Links
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
Date:11/14/2012

ng for events that occur after the date of this press release. PALATIN TECHNOLOGIES, INC.and SubsidiaryConsolidated Statements of Operations(unaudited)Three Months Ended September 30,20122011REVENUES:

$
3,806$
27,217OPERATING EXPENSES:Research and development

2,343,3132,284,383General and administrative

1,061,0161,109,382Total operating expenses

3,404,3293,393,765Loss from operations

(3,400,523)(3,366,548)OTHER INCOME (EXPENSE):Investment income

14,37115,040Interest expense

(2,282)(2,973)Increase in fair value of warrants

(7,069,165)-Gain on disposition of supplies and equipment

4,620-Total other income (expense), net

(7,052,456)12,067NET LOSS

$
(10,452,979)$
(3,354,481)Basic and diluted net loss per common share

$
(0.15)$
(0.10)Weighted average number of common shares
outstanding used in computing basic and diluted net
loss per common share

71,669,17034,900,591PALATIN TECHNOLOGIES, INC.and SubsidiaryConsolidated Balance Sheets(unaudited)September 30, 2012June 30, 2012ASSETSCurrent assets:Cash and cash equivalents

$
33,461,066$
3,827,198Accounts receivable

31,43727,631Restricted cash

-350,000Prepaid expenses and other current assets

851,844532,010Total current assets

34,344,3474,736,839Property and equipment, net

299,735318,653Other assets

58,748324,992Total assets

$
34,702,830$
5,380,484LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Capital lease obligations

$
22,707$
22,277Accounts payable 

321,621294,894Accrued expenses

1,285,2152,706,496Accrued compensation

-433,333Total current liabilities

1,629,5433,457,000Capital lease obligations 

14,06819,909Deferred rent

63,37272,677Total liabilities

1,706,9833,549,586Stockholders' equity:Preferred stock of
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Research and Markets ... Genomics Market 2014-2018" report to their offering. ... is the study of the genetic material or genomes ... strong basis for the discovery and development of diagnostic ... or health conditions. Genomics is supported by three major ...
(Date:7/31/2014)... Francisco, Calif. (PRWEB) July 31, 2014 ... newly diagnosed patients with an overview of the disease ... management of drug side effects, as well as updates ... “We’re grateful to Dr. Sandy Srinivas for organizing this ... survivor of kidney cancer. “Sandy and her colleagues have ...
(Date:7/31/2014)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... for cells and tissues, today announced today that ... released on Thursday, August 7, 2014, and that the ... at 4:30 p.m. ET that afternoon. Management will provide ...
(Date:7/30/2014)... JOLLA, Calif. , July 30, 2014 ... ), a biopharmaceutical company leading the discovery and development ... will report financial results and highlights for the quarter ... after the U.S. financial markets close. ... Wednesday, August 6, 2014, at 5:00 pm Eastern Daylight ...
Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... SYDNEY, Australia, Oct. 3 /Xinhua-PRNewswire-FirstCall/ --,Pharmaceutical company Pharmaxis ... present 12 abstracts from its respiratory disease,program at ... held,in Berlin from the 4th to the 8th ... top respiratory researchers and clinicians to hear latest,advances ...
... 2 Alba Therapeutics Corporation today,announced the promotions of ... Mark Ginski, PhD, and Kate Huber. "We are pleased,to ... and we are,fortunate to have such a fine group ... for unmet medical needs of patients with celiac,disease, asthma, ...
... FOR LEAD DRUG CANDIDATE ARIKACE(TM) DRIVES,CONTINUED CLINICAL EXPANSION, ... Inc., a,biopharmaceutical company focused on developing innovative inhaled,pharmaceuticals ... announced that it has secured a $12.5 million ... Company LLC, an affiliate of Horizon,Technology Finance Management ...
Cached Biology Technology:Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 2Pharmaxis Research Programs Highlighted at European Respiratory Society Congress 3Alba Therapeutics Corporation Announces Promotions 2Alba Therapeutics Corporation Announces Promotions 3Alba Therapeutics Corporation Announces Promotions 4Transave, Inc. Secures $12.5 Million in New Financing 2Transave, Inc. Secures $12.5 Million in New Financing 3Transave, Inc. Secures $12.5 Million in New Financing 4Transave, Inc. Secures $12.5 Million in New Financing 5
(Date:7/31/2014)... University researchers have completed a 20-year study that ... prairie at different times of the year. It ... spring time frame has no measurable negative consequences ... multiple benefits. , The study was conducted by ... Biological Station fire chief, and Joseph Craine, research ...
(Date:7/31/2014)... to loud noise alters how the brain processes ... sounds, according to neuroscientists at The University of ... this week in Ear and Hearing , ... hearing loss affects the brain,s recognition of speech ... corners of the population, affecting an estimated 15 ...
(Date:7/31/2014)... Oren Tessler, Assistant Professor of Clinical Surgery at LSU ... part of a team of plastic and reconstructive surgeons ... to screen and select patients for a specific surgical ... who underwent this surgery to decompress the nerves that ... cosmetic eyelid surgery. The study, which confirms the benefit ...
Breaking Biology News(10 mins):Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3UT Dallas study reveals effect of loud noises on brain 2Surgeons report significant migraine relief from cosmetic eyelid surgery technique 2
... UTRECHT, The Netherlands, September 10 , ... Powers Privacy-Enhancing Biometric,Technology , WCC ... search,and match software, today announced its collaboration with priv-ID, ... anonymity for,the user. The collaboration will provide enhanced identification ...
... , , , , ... leader in fingerprint identity and authentication solutions, today announced that ... fingerprint sensor as an option on NCR,s next-generation integrated point-of-sale (POS) ... The fingerprint sensor, which is embedded in the top ...
... , , BEDFORD, ... ), a global provider of imaging and biometrics software, today ... development services to Lockheed Martin,s high-performance fingerprint card scanning service. ... Martin a five-year, $47 million contract to continue managing the ...
Cached Biology News:WCC Smart Search & Match and Priv-ID Announce Global Collaboration 2WCC Smart Search & Match and Priv-ID Announce Global Collaboration 3NCR Embeds DigitalPersona U.are.U(R) 4500HD Fingerprint Sensor in New NCR RealPOS(TM) 70XRT Point-of-Sale Workstations 2Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 2Aware Software and Development Services Enable State-of-the-Art Fingerprint Card Scanning 3
... Y2 Receptor antiserum This NPY Y2 ... level and is currently being characerized in brain. ... and mouse and appears to work better on ... rat. For full characterizarion in dorsal root ganglion ...
RECK (F-20)...
Black Polypropylene 384 Round Well Plate 70/Box...
... 1 Peroxiredoxin (Prx) is a ... have been known to connect with ... isoforms (about 50 proteins), collected in ... homology, particularly amino-terminal region containing active ...
Biology Products: